As we know, entecavir is a DNA analogue that can inhibit HBV reverse transcription, by integrating itself into HBV genome during viral replication and blocking the cccDNA formation due to lack of hydroxyl group.

But I don't understand how it integrates into the HBV genome, is it through complementary machinery or just integrating into the viral genome randomly?

More Shirley Lin's questions See All
Similar questions and discussions